🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

RecruitingPhase 3Ages 18 Years - 40 YearsFemaleChinese University of Hong Kong
NCT03902912 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to investigate the role of uNK cells and the association with prednisolone.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Women with a history of 3 or more consecutive miscarriages 2. Women younger than 40 years old Exclusion Criteria: 1. Allergy to prednisolone 2. Women who have any uterine anomaly 3. Antiphospholipid syndrome 4. Hydrosalpinx 5. Thrombophilia 6. Abnormal thyroid function tests 7. women with diabetes,
💊

What it tests

  • Prednisolone
📍

Where

1 site
The Chinese University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy